Home › Janssen, Bayer HealthCare announce results from landmark studies...
 

Keywords :   


Janssen, Bayer HealthCare announce results from landmark studies...

2015-09-02 08:58:45| Chemicals - Topix.net

Janssen Pharmaceuticals, Inc., and its development partner, Bayer HealthCare, today announced results from PMSS and XANTUS , their landmark real-world studies evaluating the safety of XARELTO in people with non-valvular atrial fibrillation . The results found the rates and patterns of major bleeding in routine clinical practice were low and generally consistent with those observed in Phase 3 clinical research.

Tags: results studies healthcare announce

Category:Chemicals

Latest from this category

All news
23.11Weekly Recap: PPG, John Morikis, Sika Top This Weeks Stories
22.11Andrea Wagner Watts to Deliver Keynote Address at ACAs 2025 CoatingsTech Conference
22.11Hempels Infinity Silicone Hull Paint Recharger Launched for Yachts
22.11The Lehigh 56th Annual Short Course Website is Open
21.11allnex Announces Strategic Investment in East St. Louis Site
21.11Syensqo Expands Polymer Production Capacity
21.11¦nie¿ka Publishes Results for Three Quarters of 2024
21.11Sheboygan Paint Company Names New Customer Service Manager
Chemicals »
24.1120225//
24.112012()
24.11oasis 2022 morning
24.11Bianchi San marco xr3
24.11()
24.11PS2
24.11
24.11 HD DVD BOX
More »